Register for this webinar to learn how unified data and trustworthy AI drive precision across the pharmaceutical value chain.
Pharma teams don’t just need more data — they need a unified data picture to make faster, better decisions. In this session, the featured speakers will show how Norstella breaks down siloes by connecting clinical outcomes, real‑world evidence, market/access data and strategic intelligence into a unified ecosystem that leading pharma rely on as a foundational layer. Building on rigorous governance, the application of trustworthy, explainable AI — augmented by knowledge graphs — makes it possible to uncover hidden patterns, relationships and insights that siloed tools routinely miss.
And it’s time to move away from asking “Are we using AI?” to asking “How well are we using it?” This session will demonstrate practical applications across the value chain. Examples for accelerating recruitment include optimizing protocol design and feasibility and recommending best-fit investigators and high-performing sites by blending patient access, experience and congestion signals. It will also show how trustworthy AI strengthens market forecasting by triangulating assumptions against live competitive and epidemiological dynamics, and connecting clinical, commercial and access signals to elevate strategic planning — from portfolio choices to launch and beyond.
Because everything is connected, attendees will see how strategic choices cascade into Net Present Value (NPV) and probability of technical and regulatory success (PTRS), and the operational considerations for protocol optimization and predicted enrollment velocity, alongside enhanced feasibility — all in one coherent view.
The result: Teams move from fragmented data to connected insights, and from siloed data to actionable recommendations, with the transparency, quality and scale to “get it right.” If the goal is to reduce risk, compress timelines and raise confidence from pipeline to patient, this is the blueprint to follow.
Skye Hodson, PhD
VP Clinical Solutions, Citeline
Skye is a Biochemist with over 10 years of life sciences CRO and CCO experience, delivering tangible business outcomes across strategy, product development, clinical operations, commercialization and growth. He focuses on leveraging enabling technologies to accelerate the development of new medicines, having seen firsthand how data-driven insights and advanced analytics/AI can unlock real value for patients and companies. He is passionate about disrupting the status quo and advancing holistic health agendas, engaging with the community as a speaker, mentor and advocate for innovation in life sciences.
Ritupriya Yamujala
VP Solution Consulting, Norstella
Ritupriya holds a Master of Business and Science in Biotechnology and Genomics, with over a decade of experience in Life Sciences market intelligence, business development, and go-to-market strategy. She has worked with a wide range of large and mid-sized pharmaceutical companies, biotechs, service providers to the pharmaceutical industry, and financial and consulting firms, providing strategic insights on key business questions across multiple phases of pipeline development. With a deep, firsthand understanding of the hurdles that pharma companies face in bringing critical therapies to market, she is excited about the evolving use of AI in life sciences and pharma as an enabler of faster results and an enhancer of complex workflows.
Attendees will gain insight into: